U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H37ClN4O.2ClH
Molecular Weight 553.994
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOCAPRAMINE DIHYDROCHLORIDE ANHYDROUS

SMILES

Cl.Cl.NC(=O)C1(CCN(CCCN2C3=CC=CC=C3CCC4=C2C=C(Cl)C=C4)CC1)N5CCCCC5

InChI

InChIKey=UUTRFZNTTSPNOY-UHFFFAOYSA-N
InChI=1S/C28H37ClN4O.2ClH/c29-24-12-11-23-10-9-22-7-2-3-8-25(22)33(26(23)21-24)18-6-15-31-19-13-28(14-20-31,27(30)34)32-16-4-1-5-17-32;;/h2-3,7-8,11-12,21H,1,4-6,9-10,13-20H2,(H2,30,34);2*1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C28H37ClN4O
Molecular Weight 481.073
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://www.kegg.jp/medicus-bin/japic_med_product?id=00048317-003 | http://en.pharmacodia.com/web/drug/1_10640.html

Clocapramine is a chlorinated derivative of carpipramine. The hydrochloride has been given orally in the treatment of schizophrenia. Clocapramine is an antagonist of the Dopamine D2 and Serotonine (5-HT2) receptors. It has been implicated in at least one strange death, including a suicide. It augments the paroxetine in the panic disorder treatment.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
13.0 nM [Ki]
1.9 nM [Ki]
1.5 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CLOFEKTON

Approved Use

Clofekton 10% is indicated for the treatment of schizophrenia.

Launch Date

1974
PubMed

PubMed

TitleDatePubMed
A crossover study of clocapramine and haloperidol in chronic schizophrenia.
1985
Clocapramine-related fatality. Postmortem drug levels in multiple psychoactive drug poisoning.
2001 Oct 15
Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
2004 Nov 26
Augmentation of paroxetine with clocapramine in panic disorder.
2007 Aug
Patents

Sample Use Guides

30 to 150 mg daily in three divided doses
Route of Administration: Oral
In Vitro Use Guide
Various concentrations of clocapramine was applied to NCB20 cells and reward currents were recorded. The cells were voltage-clamped at -60 mV. The compositions of internal and external solutions were both normal. Concentration-response curves for each compound were obtained from 6 to 10 cell. The Hill coefficients of clocapramine was 0.79. The Ka values for these compounds was 1.1 uM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:42:46 GMT 2023
Edited
by admin
on Sat Dec 16 05:42:46 GMT 2023
Record UNII
K7UMH49J6Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOCAPRAMINE DIHYDROCHLORIDE ANHYDROUS
Common Name English
Clocapramine hydrochloride [WHO-DD]
Common Name English
CLOCAPRAMINE HYDROCHLORIDE ANHYDROUS
Common Name English
(1,4'-BIPIPERIDINE)-4'-CARBOXAMIDE, 1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)-, HYDROCHLORIDE (1:2)
Systematic Name English
CLOCAPRAMINE DIHYDROCHLORIDE [MI]
Common Name English
3-CHLORO-5-(3-(4-PIPERIDINO-4-CARBAMOYLPIPERIDINO)PROPYL)-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPINE DIHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
CAS
28058-62-0
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
SMS_ID
100000087950
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
PUBCHEM
34129
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
ECHA (EC/EINECS)
248-805-8
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
EPA CompTox
DTXSID20950770
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
FDA UNII
K7UMH49J6Q
Created by admin on Sat Dec 16 05:42:46 GMT 2023 , Edited by admin on Sat Dec 16 05:42:46 GMT 2023
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY